Facility Evaluation Report

On June 19, 2025, a non-compliance conference was conducted. The purpose of this conference meeting was to address non-compliance at the facility after being issued 7 Type A citations and 23 substantiated complaint allegations since being licensed July 27, 2021. Present in the meeting was CCLD staff, including Regional Manager Alycia Rayner, Licensing Program Manager Lauren Crocker, Licensing Program Analyst Michael Hood, and facility staff, including the Administrator Pouya Ansari, Vice President of Operations Terry Ervin, Senior Vice President of Operations Scott Carlson, Vice President of Quality Assurance and Regulatory Affairs Sue McPherson, Regulatory Director of Quality Assurance Kevin Wrigley, Northern California Director of Health Services Melissa Malek, and Partner at Hanson Bridgett Law Firm Joel Goldman. The conference process was explained during this meeting.

Issues discussed during this meeting were:

· An overview of citations issued on August 29, 2023

· Repeat violations regarding medication errors - medication management

The facility has stated that they will do the following to achieve continued and substantial compliance:

· Enforce systems in place for quality assurance of medication management & observation of residents

· Ensure staff competency following required training

Facility was notified that the Department may increase monitoring at the facility and the completing the Non-Compliance Conference does not deprive the Department of its authority to take appropriate formal legal action under the Health and Safety Code if such action is deemed necessary by the Regional Manager.

Exit interview was conducted and a copy of this report was provided. Signature on these forms acknowledges receipt of these documents.